About

Garth Sutherland is the Founder of Adherium. Formerly its CEO, he founded Adherium (formerly known as Nexus6) in 2001. He is an inventor of 13 patent families related to the Smartinhaler™ platform and a contributor to over 70 registered designs and several trademarks registered or used by Adherium. Prior to Adherium, Mr Sutherland worked in a variety of commercial, marketing and engineering roles. He has spent over 20 years working for some of the world’s top technology companies in Europe, North America and Australasia including Microsoft and Gallagher Group. Mr Sutherland graduated with a Masters of Science in Physics from the University of Waikato, New Zealand, with First-Class Honours. Mr Sutherland has held no other Australian public company directorships in the last three years.

Contributions

EXPERT VIEW

THE POTENTIAL OF CONNECTED DEVICES FOR TACKLING ASTHMA

Garth Sutherland and Jon-Paul Sherlock explain how a strategic partnership between pharmaceutical companies and digital health companies can achieve improved outcomes through joint initiatives.

More contributions

CONNECTIVITY

CONNECTED INHALERS MAKING A REAL IMPACT ON RESPIRATORY OUTCOMES

Garth Sutherland describes the problem of chronic non-adherence in asthma and COPD, how Adherium’s Smartinhaler™ solutions have proved themselves in the clinic, and why now is the time to move to real-world scale.